Dr. Jim Lalonde
About Dr. Jim Lalonde
Dr. Jim Lalonde is a distinguished chemist and chairman known for leading successful biotech R&D teams and developing the CodeEvolver Protein Engineering technology.
Professional Title and Leadership Roles
Dr. Jim Lalonde holds the position of Chairman and has an extensive background in leading highly performing biotech R&D teams. His leadership experience includes positions at Altus Biologics, Codexis, and Inscripta. His roles have focused on advancing research and development initiatives, particularly in the field of biotechnology.
Development of CodeEvolver Protein Engineering
Dr. Lalonde has been instrumental in developing the CodeEvolver Protein Engineering technology. This best-in-class technology has set new standards in protein engineering. The innovation behind CodeEvolver has contributed significantly to the field and has positioned Dr. Lalonde as a key figure in biotechnology advancements.
Commercialization of Pharmaceutical Processes
Under Dr. Lalonde's leadership, his teams have developed and commercialized processes for over 25 pharmaceutical actives. Notably, they have worked on blockbusters such as Lipitor, Januvia, and Paxlovid. These successes underscore his impact on the pharmaceutical industry and the practical applications of his teams' research.
Recognition and Awards
Dr. Jim Lalonde has been recognized with three U.S. Presidential Green Chemistry Awards. These prestigious awards highlight his contributions to green chemistry and his commitment to sustainable scientific practices. Such accolades further establish his reputation in the scientific community.
Educational Background
Dr. Lalonde holds a PhD in Organic Chemistry from Texas A&M University. He also earned an Honours BSc from Lakehead University. His solid educational background has provided a strong foundation for his research and leadership in biotechnology.
Scientific Advisory Roles
In addition to his primary roles, Dr. Lalonde serves as a scientific advisor to several start-up companies. His expertise and guidance are valuable to emerging ventures in the biotech field, aiding them in navigating the complexities of research and development.